Newsbenzinga
Bearish Sentiment: Biomea Fusion Scraps Equity Offering, Delays Study Data
· Published
Article summary
Biomea Fusion stock falls after ending a public securities offering and revising clinical data timelines for its obesity trial.
An excerpt from the original article.
Comments —
Loading comments…